Correlation Between Monte Rosa and NewAmsterdam Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and NewAmsterdam Pharma, you can compare the effects of market volatilities on Monte Rosa and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and NewAmsterdam Pharma.

Diversification Opportunities for Monte Rosa and NewAmsterdam Pharma

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Monte and NewAmsterdam is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Monte Rosa i.e., Monte Rosa and NewAmsterdam Pharma go up and down completely randomly.

Pair Corralation between Monte Rosa and NewAmsterdam Pharma

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 3.48 times more return on investment than NewAmsterdam Pharma. However, Monte Rosa is 3.48 times more volatile than NewAmsterdam Pharma. It trades about 0.08 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.13 per unit of risk. If you would invest  639.00  in Monte Rosa Therapeutics on August 29, 2024 and sell it today you would earn a total of  221.00  from holding Monte Rosa Therapeutics or generate 34.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  NewAmsterdam Pharma

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.
NewAmsterdam Pharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Monte Rosa and NewAmsterdam Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and NewAmsterdam Pharma

The main advantage of trading using opposite Monte Rosa and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.
The idea behind Monte Rosa Therapeutics and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account